Vermillion

VRML NASDAQ
0.8390
-0.0200
-2.33%
Closed 16:00 07/17 EDT
Open
0.8599
Prev Close
0.8590
High
0.8599
Low
0.8295
Volume
152.43K
Avg Vol (3M)
161.17K
52 Week High
1.570
52 Week Low
0.2701
% Turnover
0.16%
Market Cap
81.54M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Vermillion VRML stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.
MORE >

Recently

Name
Price
%Change